A Potential Innovative Therapy for Parkinson’s Disease: Selective Destruction of the Pathological Assemblies of Alpha-Synuclein (original) (raw)
Pharmacological targeting of α‐synuclein and TPPP /p25 in Parkinson's disease: challenges and opportunities in a Nutshell
Judit Ovádi
FEBS Letters
View PDFchevron_right
Can α-synuclein be targeted in novel therapies for Parkinson’s disease?
Patrik Brundin
Expert Review of Neurotherapeutics, 2011
View PDFchevron_right
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson’s Disease
Ruth Perez, Matthew Benskey, Fredric Manfredsson
View PDFchevron_right
Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease
Diana Lázaro
Experimental Neurology, 2017
View PDFchevron_right
Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
Luis Gerardo Aguayo
Frontiers in Neuroscience, 2015
View PDFchevron_right
Challenging Drug Target for Parkinson's Disease: pathological complex of the chameleon TPPP/p25 and alpha-synuclein proteins
Judit Ovádi
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016
View PDFchevron_right
Clues to how alpha-synuclein damages neurons in Parkinson's disease
David Sulzer
Movement Disorders, 2010
View PDFchevron_right
The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
Oxana Klementieva
Acta Neuropathologica Communications, 2021
View PDFchevron_right
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Michael Schlossmacher
npj Parkinson's Disease
View PDFchevron_right
Defining α-synuclein species responsible for Parkinson disease phenotypes in mice
Drake Thrasher
Journal of Biological Chemistry
View PDFchevron_right
Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant α-Synuclein in Human and Transgenic Mouse Brain
Manuela Neumann
The Journal of Neuroscience, 2000
View PDFchevron_right
The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
Marina Pizzi
Neural plasticity, 2017
View PDFchevron_right
Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s disease
Simona Eleuteri
Brain, 2016
View PDFchevron_right
Interactions Among α-Synuclein, Dopamine, and Biomembranes: Some Clues for Understanding Neurodegeneration in Parkinson's Disease
Tiago F Outeiro
Journal of Molecular Neuroscience, 2004
View PDFchevron_right
Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches
Marija Vidovic
Cells
View PDFchevron_right
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Viviana Brembati
Frontiers in Molecular Neuroscience, 2023
View PDFchevron_right
Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease
Chuanhai Cao
International Journal of Molecular Sciences
View PDFchevron_right
The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease
Asma Khan
Scientific reports, 2018
View PDFchevron_right
Modification of α-Synuclein by Phosphorylation: A Pivotal Event in the Cellular Pathogenesis of Parkinson’s Disease
kavina ganapathy
Protein Phosphorylation, 2017
View PDFchevron_right
Physiology and Pathophysiology of α-Synuclein: Cell Culture and Transgenic Animal Models Based on a Parkinson's Disease-associated Protein
Laurence Ozmen
Annals of the New York Academy of Sciences, 2006
View PDFchevron_right
Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease
Bernard Schneider
Biomolecules, 2015
View PDFchevron_right
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease
Igor Tsigelny
Brain : a journal of neurology, 2016
View PDFchevron_right
alpha -Synuclein Fibrillogenesis Is Nucleation-dependent. IMPLICATIONS FOR THE PATHOGENESIS OF PARKINSON'S DISEASE
Martin Citron
Journal of Biological Chemistry, 1999
View PDFchevron_right
Role of α- and β-Synucleins in the Axonal Pathology of Parkinson's Disease and Related Synucleinopathies
Kazunari Sekiyama
Biomolecules, 2015
View PDFchevron_right
Mapping the Subcellular Distribution of α-Synuclein in Neurons using Genetically Encoded Probes for Correlated Light and Electron Microscopy: Implications for Parkinson's Disease Pathogenesis
Daniela Boassa
2013
View PDFchevron_right
Mapping the Subcellular Distribution of -Synuclein in Neurons using Genetically Encoded Probes for Correlated Light and Electron Microscopy: Implications for Parkinson's Disease Pathogenesis
Mark Ellisman
Journal of Neuroscience, 2013
View PDFchevron_right
Faculty of 1000 evaluation for Mapping the Subcellular Distribution of α-Synuclein in Neurons using Genetically Encoded Probes for Correlated Light and Electron Microscopy: Implications for Parkinson's Disease Pathogenesis
Antonio Suppa
F1000 - Post-publication peer review of the biomedical literature, 2013
View PDFchevron_right
Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease
Marina Romero-ramos
Scientific reports, 2017
View PDFchevron_right
Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association
Razan Sheta
Biomolecules
View PDFchevron_right
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain
Laurence Ozmen
Journal of …, 2000
View PDFchevron_right
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
Rosario Moratalla
Frontiers in Pharmacology
View PDFchevron_right
Central Role of α-Synuclein Oligomers in Neurodegeneration in Parkinson Disease
Alexander Kolchinsky
Archives of neurology, 2008
View PDFchevron_right
Functionally different α-synuclein inclusions yield insight into Parkinson’s disease pathology
Joost le feber
Scientific Reports, 2016
View PDFchevron_right
Potential Contribution of α-Synuclein Dysregulation to Parkinson's Disease Pathology
Ruth Perez
View PDFchevron_right
POTENTIAL CONTRIBUTION OF ΑLPHA-SYNUCLEIN DYSREGULATION TO PARKINSON'S DISEASE PATHOLOGY
Ruth Perez
View PDFchevron_right